Victrex (LON:VCT - Get Free Report) was downgraded by investment analysts at Deutsche Bank Aktiengesellschaft to a "hold" rating in a report issued on Tuesday, Marketbeat reports. They currently have a GBX 850 ($11.55) price target on the stock, down from their previous price target of GBX 990 ($13.45). Deutsche Bank Aktiengesellschaft's price objective suggests a potential upside of 16.76% from the company's previous close.
Separately, JPMorgan Chase & Co. decreased their target price on shares of Victrex from GBX 940 ($12.77) to GBX 818 ($11.11) and set a "neutral" rating on the stock in a research report on Wednesday.
Get Our Latest Report on VCT
Victrex Stock Performance
Victrex stock traded up GBX 9 ($0.12) during trading hours on Tuesday, hitting GBX 728 ($9.89). The company had a trading volume of 134,664 shares, compared to its average volume of 416,815. The firm has a market cap of £635.05 million, a PE ratio of 20.68, a PEG ratio of 1.92 and a beta of 0.69. The company has a debt-to-equity ratio of 10.93, a current ratio of 4.39 and a quick ratio of 1.99. Victrex has a one year low of GBX 667.62 ($9.07) and a one year high of GBX 1,160 ($15.76). The firm has a 50-day moving average of GBX 795.78 and a 200 day moving average of GBX 890.75.
Victrex (LON:VCT - Get Free Report) last released its quarterly earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.31) earnings per share for the quarter. Victrex had a net margin of 10.81% and a return on equity of 6.67%. On average, sell-side analysts expect that Victrex will post 73.1078905 earnings per share for the current year.
Insider Buying and Selling
In other Victrex news, insider Dame Vivienne Cox bought 2,747 shares of the firm's stock in a transaction on Tuesday, July 8th. The shares were purchased at an average price of GBX 721 ($9.79) per share, for a total transaction of £19,805.87 ($26,906.49). Also, insider David Thomas purchased 1,158 shares of Victrex stock in a transaction that occurred on Tuesday, May 13th. The shares were purchased at an average price of GBX 846 ($11.49) per share, for a total transaction of £9,796.68 ($13,308.90). Corporate insiders own 1.64% of the company's stock.
About Victrex
(
Get Free Report)
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Featured Stories
Before you consider Victrex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.
While Victrex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
